Multiple myeloma-associated VTE risk prediction. A talk report from the 10th ICTHIC
During the 10th ICTHIC, prof Kristen Sanfilippo (Assistant Professor at the Washington University School of Medicine in...
Thrombosis and cancer
The TESEO registry and how it can help patients with CAT
Cancer-associated thrombosis management is incredibly challenging because of the high risk of recurrence and severe...
VTE in Palliative Care Patients: What do we know? A talk report from the 10th ICTHC
During the 10th ICTHIC, Professor Simon Noble (Cardiff University, UK) talked about the management of VTE in patients...
Inpatient thromboprophylaxis in cancer patients: what is the evidence? A talk report from the 10th ICTHIC
During the 10th ICTHIC, Prof. Jeffrey Zwicker (Harvard Medical School, MA, USA) gave an overview of the evidence of the...
VTE risk in patients with lung cancer
Lung cancer is associated with a very high risk of developing venous thromboembolism (VTE). In a large...
Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia and preliminary data from the MATTER study: A talk report from the 10th ICTHIC conference
During the 10th ICTHIC, Dr. Avi Leader (hematologist at Rabin Medical Center in Petah Tikva, Israel) talked about...
Cancer-associated thrombosis: mechanisms and risk factors
Blood clot generation in people with cancer follows a process distinct from the non-cancer population. Cancer tissue is...
D-dimer and its role in venous thromboembolism
D-dimer is a marker of coagulation activation and thrombotic activity. The analysis of D-dimer levels is used to...
CAT treatment in challenging patient categories: what the literature says
Patients with cancer are at high risk of venous thromboembolism (VTE). Fortunately, patient survival, diagnostic tools...
Incidental VTE: to treat or not to treat? – A debate from the 10th ICTHIC
During the 10th ICTHIC, Prof. Marcello di Nisio (University of Chieti, Italy) and Prof. Marc Carrier (Ottawa Hospital...